These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 104068)

  • 21. [Pharmacodynamics of Sustak and Nitrong in patients with angina pectoris].
    Metelitsa VI; Nikolenko SA; Nazarenko VA; Savvateev KL; Vygodin VA
    Ter Arkh; 1979; 51(1):40-9. PubMed ID: 107611
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of nitroglycerin on myocardial ischemia and its clinical manifestations in severe coronary heart disease.
    Amsterdam EA; Laslett L; Rutledge JC; Zakauddin V
    Bibl Cardiol; 1985; (39):118-28. PubMed ID: 3939511
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term effects of nitroglycerin on the heart and peripheral vessels in patients with coronary disease during rest and in frequency-induced angina pectoris].
    Westermann KW; Langbehn AF; Kugler G
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():458-61. PubMed ID: 4217505
    [No Abstract]   [Full Text] [Related]  

  • 24. Rate of onset of vasodilator effect of glyceryl trinitrate, propatylnitrate and erythrityl tetranitrate in man.
    Johnsson G; Henning M; Ablad B
    Scand J Clin Lab Invest; 1965; 17(6):600-6. PubMed ID: 4955334
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-angina and coronary dilating effect of low-dose nitroglycerin].
    Sievert H; Kober G; Schneider W; Kaltenbach M; Bussmann WD
    Z Kardiol; 1989; 78 Suppl 2():48-51; discussion 64-7. PubMed ID: 2511693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Proceedings: Influence of nitroglycerine and coronary vasodilatators on the regional myocardial circulation in coronary heart disease].
    Mösslacher H; Slany J; Imhof H
    Z Kardiol; 1974; 0(Suppl 1):34. PubMed ID: 4215253
    [No Abstract]   [Full Text] [Related]  

  • 27. [Blood circulation and hemodynamics of heart in angina pectoris].
    Heinrich K; Steim H
    Med Klin; 1974 Nov; 69(47):1956-8. PubMed ID: 4216751
    [No Abstract]   [Full Text] [Related]  

  • 28. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
    Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
    [No Abstract]   [Full Text] [Related]  

  • 29. The hemodynamic rationale of propranolol and nitroglycerin in the management of angina pectoris.
    Wiener L
    Med Times; 1970 Jun; 98(6):129-35. PubMed ID: 4986540
    [No Abstract]   [Full Text] [Related]  

  • 30. Antianginal drugs for stable angina pectoris.
    Aronow WS
    Ration Drug Ther; 1982 Jan; 16(1):1-7. PubMed ID: 6799985
    [No Abstract]   [Full Text] [Related]  

  • 31. [Progress in management of angina pectoris (author's transl)].
    Szczeklik E
    Przegl Lek; 1975; 32(7):603-7. PubMed ID: 240192
    [No Abstract]   [Full Text] [Related]  

  • 32. [Why does nitroglycerin tolerance appear?].
    Włodek L; Sokołowska M
    Postepy Hig Med Dosw; 2001; 55(5):673-85. PubMed ID: 11795202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitroglycerin--the first one hundred years: new facts about an old drug.
    Parratt JR
    J Pharm Pharmacol; 1979 Dec; 31(12):801-9. PubMed ID: 43362
    [No Abstract]   [Full Text] [Related]  

  • 34. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nitrate tolerance].
    Kinoshita M
    Kokyu To Junkan; 1988 Jun; 36(6):615-23. PubMed ID: 3146118
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparison of hemodynamic and coronary effects of 2 antianginal vasodilator drugs: nifedipine and trinitrine].
    Mérillon JP; Morgant C; Zygelman M; Beaufils P; Patart O; Chapuy JY; Gourgon R
    Arch Mal Coeur Vaiss; 1978 Aug; 71(8):913-21. PubMed ID: 101169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [High-dose transdermal nitroglycerin therapy: loss of effect within 24 hours?].
    Reiniger G; Kraus F; Dirschinger J; Blasini R; Rudolph W
    Herz; 1985 Jun; 10(3):157-62. PubMed ID: 3926612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mechanism of action of nitroglycerin. Stenosis vasodilation as a major component of the drug response.
    Dodge HT; Brown BG
    Scand J Clin Lab Invest Suppl; 1984; 173():41-5. PubMed ID: 6442001
    [No Abstract]   [Full Text] [Related]  

  • 39. [How does nitroglycerin act in angina pectoris?].
    Rasmussen K
    Tidsskr Nor Laegeforen; 1972 Jun; 92(18):1264-5. PubMed ID: 4625916
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of the effect of trinitrolong slabs and nitroglycerin tablets in patients with exertional angina pectoris].
    Martsevich SIu; Metelitsa VI
    Ter Arkh; 1981; 53(4):16-8. PubMed ID: 6789489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.